Nornicotine

Drug Profile

Nornicotine

Latest Information Update: 09 Dec 2010

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Yaupon Therapeutics
  • Class Alkaloids; Nicotine replacement therapy; Small molecules
  • Mechanism of Action Nicotinic receptor modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Neuropathic pain; Smoking withdrawal

Most Recent Events

  • 09 May 2009 Pharmacodynamics data from a preclinical trial in Neuropathic pain presented at the 28th Annual Scientific Meeting of the American Pain Society (APS-2009)
  • 20 Nov 2007 Pharmacodynamics data presented at the 37th Annual Meeting of the Society for Neuroscience (SfN-2007)
  • 02 Feb 2005 Nornicotine is available for licensing (http://www.yaupontherapeutics.com)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top